Consequently, the world saw a tremendous reduction in prostate cancer-related early diagnostic services, including prostate-specific antigen tests, digital rectal examinations, prostate biopsies, radiological investigations, diagnostic staging, etc., and a concomitant decrease in the rate of prostate cancer diagnosis [4, 5, 6]. This evidence concerns the gene KLK3 and Familial prostate cancer.